论文部分内容阅读
双氯灭痛栓剂(Suppositos Dic1ofenac Sodium)是双氯灭痛的一种新剂型,我们将其作为急诊退热剂,收到较满意的效果。现将其疗效作一初步小结。资料与方法药物来源该药由同济医科大学药学系研制,湖北江陵制药厂生产,由药学系提供已编好密码的退热栓。其中双氯灭痛每枚含双氯灭痛50mg,对照组每枚含消炎痛100mg。对象因急性发热而来急诊的病人,体温在38.2℃以上者,不论何种病因均进行试用,至完成所需观察病人数为止。其中包括急性上感12例,急性扁桃体炎9例,大叶性肺炎3例,急性泌感2例,血行播散型肺结核、急性肠炎、支气管哮喘并感染及FOU各1例。计男17例,女13例。年龄自12～70岁,
Suppositos Diclofenac Sodium is a new dosage form of diclofenac which we received as an emergency antipyretic and received satisfactory results. Now its efficacy for a preliminary summary. Materials and Methods Source of drug The drug developed by the Department of Pharmacy, Tongji Medical University, Hubei Jiangling Pharmaceutical Factory production, provided by the Department of Pharmacy has been programmed password antipyretic suppository. Diclofenac each containing diclofenac 50mg, the control group each containing indomethacin 100mg. Subjects with acute fever and emergency patients, body temperature above 38.2 ℃, regardless of what causes are tested, to complete the required number of patients observed so far. Including 12 cases of acute upper extremity, acute tonsillitis in 9 cases, lobar pneumonia in 3 cases, acute excretion in 2 cases, hematogenous disseminated pulmonary tuberculosis, acute enteritis, bronchial asthma and infection and 1 case of FOU. There were 17 males and 13 females. Age from 12 to 70 years old,